BIODESIX INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Biodesix Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Biodesix Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $93M, a 12.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $93M +$10.5M +12.7% Dec 31, 2023 10-K 2024-03-01
Q4 2022 $82.6M +$15.1M +22.4% Dec 31, 2022 10-K 2024-03-01
Q4 2021 $67.5M +$11.4M +20.3% Dec 31, 2021 10-K 2023-03-06
Q4 2020 $56.1M +$4.95M +9.68% Dec 31, 2020 10-K 2022-03-14
Q4 2019 $51.1M Dec 31, 2019 10-K 2021-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.